Improved PFS in Advanced Kidney Cancer With Antiangiogenic Combination

By News Health
24 minutes Ago

(MedPage Today) — SAN FRANCISCO — Dual antiangiogenic therapy for previously treated kidney cancer significantly improved progression-free survival (PFS) versus a single drug, a large randomized trial showed.
Median PFS improved from 10.7…

Source link : https://www.medpagetoday.com/meetingcoverage/ascogu/120094

Author :

Publish date : 2026-02-28 15:00:00

Copyright for syndicated content belongs to the linked Source.

Categories: Health News

Related Content

People Are Chilling Their Carbs to Try to Lose Weight

Not All Cardiovascular Disease Risks Start in the Heart. Here's Why

I take 120 tablets a week after mesh operation

I woke up from an operation in agony and the pain never went away

'Very Impressive' Survival With Combo in First-Line Prostate Cancer Study

More Parents Say 'No' to Vitamin K Shots for Newborns